FierceBiotech

Crucell and Harvard (BIDMC) Join Forces with IAVI to Advance AdVac®-based AIDS Vaccine

Leiden, the Netherlands (August 11, 2010) - Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announces its intention to participate in an ...
FierceBiotech

PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach

LEIDEN, The Netherlands, July 29, 2009 - The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), ...
Pressemitteilungen

Crucell and US Navy Sign Agreement to Test AdVac®-based Vaccine Against Anthrax and Plague

Leiden, The Netherlands, August 17, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) announced today that it has signed a Cooperative Research and Development Agreement (CRADA) ...
EurekAlert!

PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach

LEIDEN, The Netherlands, July 29, 2009 – The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), ...